首站-论文投稿智能助手
典型文献
Recent advances in research on natural product inhibitors of SREBPs
文献摘要:
Sterol regulatory element-binding proteins (SREBPs) are a class of cholesterol-sensitive transcription factors that play important roles in lipid metabolism. Natural product inhibitors of SREBPs have been shown to inhibit the synthesis of free fatty acids and cholesterol, promote the burning of brown fat, and relieve insulin resistance by inhibiting different links during the synthesis, cleavage, and transport of SREBPs, thereby improving obesity, diabetes, atherosclerosis, and other metabolic diseases and disorders. There are numerous Chinese herbal medicines with verified efficacy in the treatment of metabolic diseases, including Coptis chinensis Franch. and Pueraria peduncularis Grah. for diabetes, Pueraria peduncularis Grah., Epimedium brevicornum Maxim., and Panax ginseng C. A. Meyer for osteoporosis, and Nelumbo nucifera Gaertn. and Poria cocos (Schw.) Wolf. for obesity. Present-day research on the mechanisms underlying the activity of traditional Chinese medicine has indicated that certain chemical components of these traditional preparations can be used to treat metabolic diseases by inhibiting SREBPs. Progress in the research on natural product SREBP inhibitors is continuing apace, and the mechanisms of action of certain small molecules have become well established. In this study, we review recent progress in the research on natural small-molecule inhibitors of SREBPs, including flavonoids, saponins, triterpenoids, and alkaloids, which we hope will provide a useful reference for future research and development of drugs for the treatment of metabolic diseases.
文献关键词:
作者姓名:
Yi-Ping Zhang;Jing Jin;Ping Li;Hua Yang;Zu-Guo Zheng
作者机构:
State Key Laboratory of Natural Medicines,Department of Pharmacognosy,School of Traditional Chinese Pharmacy,China Pharmaceutical University,Nanjing 210009,China.
引用格式:
[1]Yi-Ping Zhang;Jing Jin;Ping Li;Hua Yang;Zu-Guo Zheng-.Recent advances in research on natural product inhibitors of SREBPs)[J].传统医学研究(英文版),2022(03):55-67
A类:
peduncularis,Grah,brevicornum,apace
B类:
Recent,advances,research,natural,product,inhibitors,SREBPs,Sterol,regulatory,element,binding,proteins,are,class,cholesterol,sensitive,transcription,factors,that,play,important,roles,lipid,metabolism,Natural,have,been,shown,synthesis,free,fatty,acids,promote,burning,brown,relieve,insulin,resistance,inhibiting,different,links,during,cleavage,transport,thereby,improving,obesity,diabetes,atherosclerosis,other,metabolic,diseases,disorders,There,numerous,Chinese,herbal,medicines,verified,efficacy,treatment,including,Coptis,chinensis,Franch,Pueraria,Epimedium,Maxim,Panax,ginseng,Meyer,osteoporosis,Nelumbo,nucifera,Gaertn,Poria,cocos,Schw,Wolf,Present,day,mechanisms,underlying,activity,traditional,has,indicated,certain,chemical,components,these,preparations,can,used,Progress,continuing,action,small,molecules,become,well,established,In,this,study,review,recent,progress,flavonoids,saponins,triterpenoids,alkaloids,which,hope,will,provide,useful,reference,future,development,drugs
AB值:
0.59889
相似文献
Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation
Shuyin Bao;Xiuzhi Wang;Qianqian Ma;Chengxi Wei;Jixing Nan;Wuliji Ao-Institute of Pharmaceutical Chemistry and Pharmacology,Inner Mongolia Minzu University,Tongliao 028000,China;Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System,Tongliao 028000,China;Jilin Key Laboratory for Traditional Chinese Korean Medicine,College of Pharmacy,Yanbian University,Yanji 133002,China;Department of Medicines and Foods,Tongliao Vocational College,Tongliao 028000,China;Research and development center,Inner Mongolia Research Institute of Traditional Mongolian Medicine Engineering Technology,Tongliao 028000,China;Mongolian Medicine R&D National Local Union Engineering Research Center,Inner Mongolia Minzu University,Tongliao 028000,China
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。